The estimated Net Worth of Capital, Llc Boxer Asset Ma... is at least $34 Milhão dollars as of 25 September 2020. Capital Ma owns over 950,000 units of Pmv Pharmaceuticals Inc stock worth over $1,434,500 and over the last 4 years Capital sold PMVP stock worth over $32,578,000.
Capital has made over 2 trades of the Pmv Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Capital sold 700,000 units of PMVP stock worth $32,578,000 on 3 January 2022.
The largest trade Capital's ever made was buying 950,000 units of Pmv Pharmaceuticals Inc stock on 25 September 2020 worth over $17,100,000. On average, Capital trades about 825,000 units every 233 days since 2020. As of 25 September 2020 Capital still owns at least 950,000 units of Pmv Pharmaceuticals Inc stock.
You can see the complete history of Capital Ma stock trades at the bottom of the page.
Over the last 4 years, insiders at Pmv Pharmaceuticals Inc have traded over $56,359,813 worth of Pmv Pharmaceuticals Inc stock and bought 3,910,000 units worth $70,380,000 . The most active insiders traders include Peter A. Thompson, Capital Management, L.P.Kol..., eThilo Schroeder. On average, Pmv Pharmaceuticals Inc executives and independent directors trade stock every 16 days with the average trade being worth of $130,810. The most recent stock trade was executed by Advisors Llc Orbi Med Capit... on 22 November 2023, trading 87,786 units of PMVP stock currently worth $195,763.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
Pmv Pharmaceuticals Inc executives and other stock owners filed with the SEC include: